Titan Pharmaceuticals, Inc. (TTNP)

Titan Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for TTNP.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for TTNP.

Recommendation Trends

Rating	Dec '21	Jan '22	Feb '22	Mar '22	Apr '22	May '22
Strong Buy	1	1	1	1	1	0
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	May 26, 2022
Jason McCarthy Maxim Group	Maxim Group	Hold → Strong Buy Upgrades $220	Hold → Strong Buy	Upgrades	$220	+2,905.88%	Feb 18, 2021
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Aug 17, 2020
Jason McCarthy Maxim Group	Maxim Group	Hold → Strong Buy Upgrades $600	Hold → Strong Buy	Upgrades	$600	+8,097.84%	Oct 23, 2019
Scott Henry Roth Capital	Roth Capital	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Nov 10, 2017

More Analyst Ratings

Financial Forecast

• Revenue Next Year:
  n/a
• EPS This Year:
  n/a
• EPS Next Year:
  n/a

Year	2019	2020	2021	2022	2023
Revenue	2.61M	4.84M	1.53M	557.00K	184.00K
Revenue Growth	-60.64%	85.72%	-68.46%	-63.50%	-66.97%
EPS	-429.80	-96.60	-18.00	-15.19	-7.41
EPS Growth	-	-	-	-	-
No. Analysts	-	-	-	-	-

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue
High
Avg
Low

Revenue Growth

Revenue Growth
High
Avg
Low

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.